Status:

COMPLETED

Effect of Bioskin Ten-7 vs. Standard Treatment on Patient Reported Outcomes and Cytokine.

Lead Sponsor:

Cropper Medical

Conditions:

Osteoarthritis of the Knee

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The objectives of the study are 1.) to evaluate pain relief following the application of the Bioskin Ten-7 knee brace and 2.) to determine if use of the Bioskin Ten-7 knee brace is more effective at r...

Detailed Description

Once consented, the patient is assigned to either Group A or Group B. Group A patients will receive standard treatment only and will not be prescribed a knee brace. Group B patients will receive stand...

Eligibility Criteria

Inclusion

  • Male or female 18 years and older with primary diagnosis of Knee OA with no other knee diagnosis.
  • Must have telephone access.

Exclusion

  • \-

Key Trial Info

Start Date :

May 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2016

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT02295020

Start Date

May 1 2013

End Date

April 1 2016

Last Update

July 11 2016

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Effect of Bioskin Ten-7 vs. Standard Treatment on Patient Reported Outcomes and Cytokine. | DecenTrialz